Alex Biese

PTCY offers improved progression-free and overall survival compared to ATG in MDS patients undergoing allo-HSCT.

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based on findings from the FELIX trial.

Ponsegromab increased weight and activity levels in cachexia patients, confirming GDF-15 as a key driver and therapeutic target.

Elevated baseline CTC count in hormone-sensitive prostate cancer is linked to worse overall survival and treatment response.

Trodelvy shows effectiveness in treating metastatic triple-negative breast cancer, supported by real-world data.

Three cycles of chemotherapy were found to face similar results as six cycles among children with retinoblastoma, a type of cancer of the eye.

Treatment for relapsed or refractory multiple myeloma includes anti-CD38 antibodies, immunomodulating agents, CAR-T cell therapies, and bispecific antibodies, with evolving options enhancing patient outcomes.

The actor, 65, received his diagnosis of stage 3 non-Hodgkin lymphoma in October, he said.

Lymphedema risk varies significantly by cancer type and lymph node removal extent, necessitating personalized risk assessments.

Neoadjuvant ICIs in hepatocellular carcinoma may predict improved relapse-free survival post-resection, as shown in a large pooled analysis.